iShares Biotechnology ETF (NASDAQ:IBB) Position Boosted by Apollon Wealth Management LLC

Apollon Wealth Management LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 16.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,658 shares of the financial services provider’s stock after purchasing an additional 1,195 shares during the quarter. Apollon Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,145,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its holdings in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares in the last quarter. Commerce Bank grew its holdings in shares of iShares Biotechnology ETF by 1.8% in the 3rd quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after acquiring an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Main Management ETF Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after purchasing an additional 14,535 shares during the last quarter. Finally, Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $136.15 on Tuesday. The business’s 50-day moving average price is $136.10 and its 200 day moving average price is $141.27. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.